文献速递细胞病理与分子病理

悉尼系统用于儿童淋巴结细胞病理学报告及恶性风险评估

Assessment of risk of malignancy with application of Sydney classification for reporting of lymph node cytopathology in pediatric population: An institutional experience.
PubMed 文献 · Cancer Cytopathol · 2025-01-01

该回顾性观察研究纳入2016-2024年印度东部三级中心803例0-18岁儿童淋巴结细针穿刺细胞学(FNAC)病例,按悉尼系统重新分类并计算诊断效能与恶性风险(ROM)。结果显示灵敏度72.34%、特异度98.48%、准确率87.61%,L2的ROM为16.67%,L4和L5均为100%,支持FNAC在儿童淋巴结病变中高度准确且特异。

要点

  • 儿童淋巴结FNAC按悉尼系统分类,L2恶性风险16.67%,L4和L5均为100%。
  • FNAC诊断灵敏度72.34%、特异度98.48%、准确率87.61%。
  • 悉尼系统有助于儿童淋巴结细胞学诊断的统一性和可重复性。

核心结论

  • FNAC对儿童淋巴结病变高度准确且特异,悉尼系统有助于诊断的统一性和可重复性。

研究设计与样本

  • 印度东部三级中心2016-2024年回顾性观察研究,纳入0-18岁儿童淋巴结FNAC病例803例并按悉尼系统重新分类。

主要发现

  • 803例中L1为35例(4.35%),L2为689例(85.8%),L3为4例(0.49%),L4为22例,L5为53例(6.6%)。
  • 灵敏度72.34%、特异度98.48%、PPV 97.14%、NPV 83.33%、准确率87.61%。
  • ROM在L2为16.67%,在L4和L5均为100%。

关键数值与推荐

  • L1为35例(4.35%),L2为689例(85.8%),L3为4例(0.49%),L4为22例,L5为53例(6.6%)。
  • 灵敏度72.34%、特异度98.48%、PPV 97.14%、NPV 83.33%、准确率87.61%。
  • ROM在L2为16.67%,在L4和L5均为100%。

临床怎么用

  • 儿童淋巴结病变可首选FNAC评估,并按悉尼系统分类报告以评估恶性风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fine-needle aspiration cytology (FNAC) has been used as the first line approach to lymphadenopathy, which is a common presentation in pediatric age group. The Sydney system for reporting of lymph node (LN) cytology has been proposed to assess the reliability, performance, and accuracy of the aspiration procedure. This study intends to assess the role of FNAC in the pediatric population according to the Sydney system. METHODS: This was a retrospective observational study from a tertiary care center in Eastern India. All the patients in the age group of 0-18 years evaluated during years 2016-2024 were reclassified according to the Sydney system. Based on the cytology and histology diagnoses, the cases were categorized into true-negative, true-positive, false-negative, and false-positive. The overall sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), accuracy, and risk of malignancy (ROM) was calculated for each category. RESULTS: Of 803 cases of pediatric LN-FNACs, 35 (4.35%) cases were reported as inadequate (L1), 689 (85.8%) cases as benign (L2), four (0.49%) cases as atypical cells of undetermined significance (L3), 22 cases as suspicious for malignancy (L4), and 53 (6.6%) cases as malignant (L5). The sensitivity, specificity, PPV, NPV, and accuracy was 72.34%, 98.48%, 97.14%, 83.33%, and 87.61%, respectively. The ROM was 16.67% for L2 and 100% for both L4 and L5 categories. CONCLUSIONS: FNAC is a highly accurate and specific test for LN pathology, especially in the pediatric population. The incorporation of the Sydney system helps to achieve uniformity and reproducibility in LN cytology diagnosis.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Sable M, Panda M, Acharya P, et al. Assessment of risk of malignancy with application of Sydney classification for reporting of lymph node cytopathology in pediatric population: An institutional experience. Cancer Cytopathol. 2025. PMID: 39902551. doi:10.1002/cncy.22936

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。